ACT Brief: Risk-Based Monitoring in Global Trials, Patient-Centered AI Design, and Generative AI in Healthcare

In today's ACT Brief, we examine the technical and operational challenges of implementing risk-based monitoring across global trials, how AI must address social determinants of health and site burden, and the emerging role of domain-specific generative AI in clinical practice.